A. Gómez-Bastero Fernández

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

Treatment of Refractory Persistent Corneal Epithelial Defects: A Standardized Approach Using Continuous Wear PROSE Therapy

Jessica Ciralsky, Kristin Chapman, Mark I. Rosenblatt et al. · Ocular Immunology and Inflammation · 2014 · 49 citations

Effects of Theophylline Compared with Prednisolone on Late Phase Airway Leukocyte Infiltration in Guinea Pigs

R.W. Gristwood, J Llupiá, A. Gómez-Bastero Fernández et al. · International Archives of Allergy and Immunology · 1991 · 22 citations

Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma

A. Gómez-Bastero Fernández, Juan Francisco Medina Gallardo, Julio Delgado Romero et al. · Journal of Asthma and Allergy · 2022 · 19 citations · Full text

Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

Renaud Louis, Tim Harrison, Pascal Chanez et al. · The Journal of Allergy and Clinical Immunology In Practice · 2023 · 19 citations · Full text